ÂÜÀòÂÒÂ×

Imola K Fodor is a highly experienced leader in the field of biostatistics and data science, currently serving as Vice President of Data & Statistical Sciences specializing in Cardiovascular, Renal, and Metabolism at Roche since July 2024. Fodor has held multiple key positions within Roche and Genentech, including Vice President roles in Hematology and Early Development Oncology, and Global Head of Oncology Biostatistics. With a strong background in statistical methods and research, Fodor has contributed significantly to drug development processes, focusing on portfolio decision-making, safety statistics, and regulatory interactions. Fodor's prior experience includes a role as Computational Mathematician at Lawrence Livermore National Laboratory, where complex data analysis was performed, further supplemented by research as a Research Assistant at the University of California, Berkeley. Fodor holds a PhD in Statistics from the University of California, Berkeley, and a BA in Mathematics, Statistics, and Physics from Rutgers University.